KRYS
Price
$204.10
Change
-$0.64 (-0.31%)
Updated
Nov 19 closing price
Capitalization
5.92B
102 days until earnings call
Intraday BUY SELL Signals
TGTX
Price
$30.33
Change
-$0.88 (-2.82%)
Updated
Nov 19 closing price
Capitalization
4.82B
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KRYS vs TGTX

Header iconKRYS vs TGTX Comparison
Open Charts KRYS vs TGTXBanner chart's image
Krystal Biotech
Price$204.10
Change-$0.64 (-0.31%)
Volume$229.08K
Capitalization5.92B
TG Therapeutics
Price$30.33
Change-$0.88 (-2.82%)
Volume$1.9M
Capitalization4.82B
KRYS vs TGTX Comparison Chart in %
KRYS
Daily Signal:
Gain/Loss:
TGTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KRYS vs. TGTX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and TGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (KRYS: $204.10 vs. TGTX: $30.33)
Brand notoriety: KRYS and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 67% vs. TGTX: 101%
Market capitalization -- KRYS: $5.92B vs. TGTX: $4.82B
KRYS [@Biotechnology] is valued at $5.92B. TGTX’s [@Biotechnology] market capitalization is $4.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileTGTX’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • TGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than TGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 3 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 3 bullish, 5 bearish.
  • TGTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TGTX is a better buy in the short-term than KRYS.

Price Growth

KRYS (@Biotechnology) experienced а +0.53% price change this week, while TGTX (@Biotechnology) price change was -2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

KRYS is expected to report earnings on Mar 02, 2026.

TGTX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($5.92B) has a higher market cap than TGTX($4.82B). KRYS has higher P/E ratio than TGTX: KRYS (30.60) vs TGTX (10.95). KRYS YTD gains are higher at: 30.282 vs. TGTX (0.764). KRYS has higher annual earnings (EBITDA): 158M vs. TGTX (97.6M). KRYS has more cash in the bank: 682M vs. TGTX (252M). KRYS has less debt than TGTX: KRYS (9.68M) vs TGTX (254M). TGTX has higher revenues than KRYS: TGTX (454M) vs KRYS (359M).
KRYSTGTXKRYS / TGTX
Capitalization5.92B4.82B123%
EBITDA158M97.6M162%
Gain YTD30.2820.7643,963%
P/E Ratio30.6010.95279%
Revenue359M454M79%
Total Cash682M252M271%
Total Debt9.68M254M4%
FUNDAMENTALS RATINGS
KRYS vs TGTX: Fundamental Ratings
KRYS
TGTX
OUTLOOK RATING
1..100
1966
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
2693
SMR RATING
1..100
5236
PRICE GROWTH RATING
1..100
3959
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGTX's Valuation (64) in the Biotechnology industry is in the same range as KRYS (77) in the Pharmaceuticals Major industry. This means that TGTX’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (26) in the Pharmaceuticals Major industry is significantly better than the same rating for TGTX (93) in the Biotechnology industry. This means that KRYS’s stock grew significantly faster than TGTX’s over the last 12 months.

TGTX's SMR Rating (36) in the Biotechnology industry is in the same range as KRYS (52) in the Pharmaceuticals Major industry. This means that TGTX’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as TGTX (59) in the Biotechnology industry. This means that KRYS’s stock grew similarly to TGTX’s over the last 12 months.

KRYS's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as TGTX (100) in the Biotechnology industry. This means that KRYS’s stock grew similarly to TGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSTGTX
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signal:
Gain/Loss:
TGTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFFCX57.270.11
+0.19%
Davis Financial C
SMCFX75.160.13
+0.17%
American Funds SMALLCAP World F2
UGOFX12.44N/A
N/A
Victory Global Managed Volatility Instl
SJVIX30.61N/A
N/A
Steward Large Cap Value I
HAINX53.37-0.26
-0.48%
Harbor International Institutional

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with ACLX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-0.31%
ACLX - KRYS
51%
Loosely correlated
-0.38%
VRDN - KRYS
49%
Loosely correlated
+0.31%
CGON - KRYS
48%
Loosely correlated
+0.16%
IDYA - KRYS
48%
Loosely correlated
-1.72%
XNCR - KRYS
48%
Loosely correlated
-1.62%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with KRYS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-2.82%
KRYS - TGTX
42%
Loosely correlated
-0.31%
ARRY - TGTX
36%
Loosely correlated
-2.47%
CLLS - TGTX
36%
Loosely correlated
+7.06%
AXON - TGTX
36%
Loosely correlated
-0.50%
PTCT - TGTX
36%
Loosely correlated
-1.42%
More